HEALIUS LIMITED — Director's Dealing 2023

Dec 3, 2023

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	HEALIUS LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Michael Stanford
Date of last notice	1 September 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest
(including registered holder)	Mrs Sally Stanford
Note: Provide details of the circumstances giving
rise to the relevant interest.
Date of change	1 December 2023
No. of securities held prior tochange	Nil
Class	Ordinary Shares
Number acquired	32,468
Number disposed	N/A
Value/Consideration
Note: If consideration is non-cash, provide details	$1.535 per Ordinary Share
and estimated valuation

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

32,468 No. of securities held after change Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under On-market trade dividend reinvestment plan, participation in buyback

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written N/A clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date was N/A this provided?

Authorised by the Company Secretary.

Mary Weaver Company Secretary Date: 4 December 2023

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011